Thomas S. Mchugh - Aug 14, 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Chief Financial Officer
Signature
/s/ Jerad G. Seurer, Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
Aug 14, 2023
Transactions value $
$28,900
Form type
4
Date filed
8/14/2023, 05:56 PM
Previous filing
Jun 5, 2023
Next filing
Jan 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $28.9K +2K +2.61% $14.45 78.5K Aug 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts.